Tempest Therapeutics, Inc.
For the period ended Dec 31, 2025. Filed Mar 30, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 30, 2026
TPST$0.37+3.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(in thousands, except share and per share amounts)
| As of December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $7,707 | $30,268 |
| Prepaid expenses and other current assets | 562 | 1,206 |
| Total current assets | 8,269 | 31,474 |
| Property and equipment — net | 605 | 886 |
| Operating lease right-of-use assets | 7,540 | 8,643 |
| Other noncurrent assets | 517 | 485 |
| Total assets | $16,931 | $41,488 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $1,038 | $2,450 |
| Accrued expenses | 937 | 2,726 |
| Current loan payable (net of discount and issuance costs of nil and $74, respectively) | — | 6,354 |
| Current operating lease liabilities | 1,192 | 869 |
| Accrued compensation | 147 | 1,762 |
| Interest payable | — | 59 |
| Total current liabilities | 3,314 | 14,220 |
| Operating lease liabilities, less current portion | 6,949 | 8,142 |
| Total liabilities | 10,263 | 22,362 |
| Commitments and contingencies (Note 5) | ||
| Stockholders’ equity: | ||
| Common stock, $0.001 par value; 100,000,000 shares authorized; 4,927,161 and 3,382,432 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively(1) | 5 | 3 |
| Additional paid-in capital(1) | 240,031 | 226,229 |
| Accumulated deficit | (233,368) | (207,106) |
| Total stockholders’ equity | 6,668 | 19,126 |
| Total liabilities and stockholders’ equity | $16,931 | $41,488 |
(1)Results, including shares issued and outstanding have been adjusted to reflect theone-for-thirteen stock split effected in April 2025. See Note 1, Organization and Description of the Business, for details.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.